This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
10/29/2025
Operator
Conference Operator
Good afternoon, ladies and gentlemen. Welcome to the NSAID Q3 2025 results presentation. I will now hand over to Mr. Ignacio Colmenares, Executive Chairman and CEO at Alfredo Avelio CFO. Gentlemen, please go ahead.
Ignacio Colmenares
Executive Chairman & CEO
Good afternoon, everyone, and thank you for joining NSAID's third quarter 2025 results presentation. Let me please start this presentation pointing out that, firstly, ENCEP Palp's division is firmly evolving towards a higher margin special pulp-centered business, substituting more expensive BSKP alternatives based on local wood sourcing and proximity service. And secondly, our local biomass backbone, renewable energy platform, continues its development, transforming the biomass nearby collected into a diversified range of energies, including regulated renewable electricity, industrial renewable heating, biomethane, and renewable fuels, with solid recurrent EVDA and tangible pipelines under execution. Today, I'm joined by our CFO, Alfredo Bello, and our IR Director, Inés Álvarez. I will begin with a brief overview of the quarter and our strategic process. Alfredo will then take you through the financials and I will return with the closing remarks.
Inés Álvarez
Director of Investor Relations
On page 4, you can find the main highlights of the quarter.
You're reading a preview of the EEYCF Q3 2025 earnings call.
Free account.
Disclaimer